Complete inhibition of phosphatase and tensin homolog promotes the normal and oxygen-glucose deprivation/reperfusion-injured PC12 cells to cell death-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complete inhibition of phosphatase and tensin homolog promotes the normal and oxygen-glucose deprivation/reperfusion-injured PC12 cells to cell death

Published:2018-05-21 Issue:2 Volume:10 Page:83-89
ISSN:2008-5117
Container-title:Journal of Cardiovascular and Thoracic Research
language:en
Short-container-title:J Cardiovasc Thorac Res

Author:

Minaei Beyrami Sohrab,Khadem Ansari Mohammad Hasan,Rasemi Yousef,Shakib Nader,Karimi Pouran

Publisher

Maad Rayan Publishing Company

Subject

Cardiology and Cardiovascular Medicine

Link

http://jcvtr.tbzmed.ac.ir/pdf/jcvtr-10-83.pdf

Reference52 articles.

1. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

2. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke

3. Tissue Plasminogen Activator for Acute Ischemic Stroke

4. Acute Stroke Reperfusion Therapy Trends in the Expanded Treatment Window Era

5. Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthocyanin attenuates oxygen-glucose deprivation/reperfusion-induced apoptosis of PC12 cells via inactivation of ASK1/JNK/p38 signaling pathway;Tropical Journal of Pharmaceutical Research;2021-07-01

2. The Mitochondrial mitoNEET Ligand NL-1 Is Protective in a Murine Model of Transient Cerebral Ischemic Stroke;Pharmaceutical Research;2021-05

3. Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injury;International Journal of Pharmaceutics;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3